Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Stomach Neoplasms × tipiracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5 Colonic Neoplasms 2 Stomach Neoplasms 1 Gastric Cancer Adenocarcinoma Metastatic 1

Interventions

Oxaliplatin 35 Fluorouracil 26 Capecitabine 20 pembrolizumab 19 Paclitaxel 18 Leucovorin 16 S 1 (combination) 13 Docetaxel 13 tislelizumab 11 Nivolumab 11 sintilimab 9 Trastuzumab 9 trastuzumab deruxtecan 8 Irinotecan 8 Drug Therapy 7 Cisplatin 7 Bevacizumab 7 fludarabine 6 XELOX 6 Surgical Procedures, Operative 6 Specimen Handling 6 Radiotherapy 6 Cyclophosphamide 6 Biopsy 6 lenvatinib 5 disitamab vedotin 5 apatinib 5 aldesleukin 5 Magnetic Resonance Spectroscopy 5 Injections 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07212933 2025-10-08

RAK in GC

Chinese PLA General Hospital

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡